225100-12-9

Upstream product

• 13162-26-0 2,4-dichloro-6-methyl-5-nitropyrimidine 
• 63211-98-3 2-Chloro-4,5-diamino-6-methylpyrimidine 
• 151450-18-9 3-cyclopentyloxy-4-methoxy-benzylamine 
• 175206-66-3 4-chloromethyl-2-cyclopentyloxy-1-methoxybenzene 
• 304905-20-2 2-chloro-6,8-dimethylpurine 
• 78-39-7 Triethyl orthoacetate 

Downstream Products

• 225099-81-0 9-[(3-cyclopentyloxy-4-methoxy)benzyl]-6,8-dimethyl-2-[3-(4-pyridyl)propyloxy]purine 

Relevant academic research and scientific papers

Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof

Dihydrate of 4-[[9-[(3-cyclopentyloxy-4-methoxy)benzyl]-6,8-dimethylpurin]-2-yl-3-oxypropyl]pyridine N-oxide, drugs containing the same and a compound useful as an intermediate in the production of this dihydrate. Because of having a phosphodiesterase IV

PURINE DERIVATIVE DIHYDRATE, DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT AND INTERMEDIATE IN THE PRODUCTION THEREOF

Dihydrate of 4-[[9-[(3-cyclopentyloxy-4-methoxy)benzyl]-6,8- dimethylpurin]-2-yl-3-oxypropyl]pyridine N-oxide, drugs containing the same and a compound useful as an intermediate in the production of this dihydrate. Because of having a phosphodiesterase IV

PURINE DERIVATIVES AND MEDICINE CONTAINING THE SAME AS THE ACTIVE INGREDIENT

Purine derivatives represented by the following formula and salts thereof: wherein R1 represents a C1-C4 alkyl group or difluoromethyl group; R2 represents tetrahydrofuranyl group, a C1-C7